Sign in to continue:

Saturday, March 7th, 2026

APEX Tech Acquisition Inc. 2026 Audited Balance Sheet & Financial Statement: IPO, Going Concern & SPAC Details

APEX Tech Acquisition Inc. Releases Audited Financial Statement: Key Takeaways for Investors

Overview

APEX Tech Acquisition Inc., a blank check company incorporated in the Cayman Islands, has released its audited balance sheet and accompanying notes for the period ending February 27, 2026. The audit was conducted by Simon & Edward, LLP, who has served as the company’s auditor since 2025. This report provides critical insights into the company’s financial position, organizational structure, and risks as it seeks to execute its initial business combination within a prescribed timeline.

Key Financial Highlights

  • Cash Position: The company held cash of \$584,080 outside its trust account as of February 27, 2026, available for working capital purposes.
  • Trust Account: \$111,971,310 is held in a trust account, which is reserved for the completion of the initial business combination or redemption of public shares.
  • Total Assets: Total assets amounted to \$112,555,390.
  • Liabilities: The balance sheet reports zero liabilities, underscoring a clean financial position but also reflecting the company’s early stage.
  • Ordinary Shares: 11,197,131 ordinary shares are subject to possible redemption, valued at \$111,971,310. An additional 3,058,254 shares are issued and outstanding, excluding those subject to redemption.
  • Shareholders’ Equity: Equity stands at \$584,080, with an accumulated deficit of \$(64,717), reflecting organizational and IPO-related expenses.

Organizational and Business Operations

APEX Tech Acquisition Inc. is a Special Purpose Acquisition Company (SPAC) formed to pursue a business combination with one or more target businesses. The company completed its IPO on February 27, 2026, selling 11,197,131 units at \$10.00 per unit, generating gross proceeds of \$111,971,310. The units consist of one ordinary share and one right to receive one-fourth (1/4) of an ordinary share upon completion of the initial business combination.

Simultaneously, the sponsor purchased 208,971 private units for \$2,089,710. These proceeds, along with the IPO proceeds, are held in the trust account until a business combination is completed.

Critical Deadlines and Going Concern Risks

  • Business Combination Deadline: The company has 15 months from the closing of the IPO (until May 27, 2027) to complete a business combination. Failure to do so will trigger automatic winding up, dissolution, and liquidation.
  • Substantial Doubt as Going Concern: The auditor and management highlighted substantial doubt about the company’s ability to continue as a going concern if a business combination is not completed within the timeframe. No adjustments have been made to asset or liability values for potential liquidation scenarios.
  • Sponsor Commitments: The sponsor has agreed to loan the company up to \$500,000 (already repaid post-IPO) and may provide up to \$2,000,000 in working capital loans, convertible into private units upon a successful business combination.

Shareholder Rights and Restrictions

  • Redemption Rights: Public shareholders can redeem their shares for cash from the trust account if a business combination is not completed.
  • Founder Shares Restrictions: The sponsor and initial shareholders have agreed to restrictions on transfer, assignment, or sale of founder shares until 180 days post-business combination or until certain price thresholds are met.
  • Lock-Up and Registration Rights: Holders of founder shares, private units, and shares issued to underwriters have registration rights and lock-up conditions. Representative and deferred compensation shares are subject to a 180-day lock-up post-offering.
  • Rights Instruments: Each unit includes a right to receive one-fourth of an ordinary share upon consummation of a business combination. These rights expire worthless if no business combination occurs within the required period.

Potential Price-Sensitive Issues

  • Uncertainty in Completion of Business Combination: The possibility of failing to complete a business combination within 15 months is a significant risk and could lead to liquidation, materially affecting share values.
  • Market Volatility and Geopolitical Risks: Ongoing global conflicts, trade tensions, and political uncertainties (including Russia/Ukraine and Hamas/Israel) may impact the company’s ability to raise financing and consummate a business combination.
  • No Taxation in Cayman Islands: The company is not subject to income taxation under Cayman Islands law.
  • Deferred and Representative Shares: The issuance of deferred compensation shares to A.G.P. and underwriters, subject to lock-up and restrictions, may affect post-business combination share supply and trading.

Recent Accounting Pronouncements and Segment Reporting

  • Adoption of ASU 2023-07: The company has adopted new segment reporting standards, although currently it operates as a single segment given its SPAC structure.
  • Emerging Growth Company Status: APEX Tech Acquisition Inc. is classified as an emerging growth company, enabling it to adopt new accounting standards at the same time as private companies, which may affect comparability with non-EGC public companies.

Conclusion

Investors should note the substantial risk associated with the company’s ability to consummate a business combination within the mandated timeframe. The company’s clean balance sheet and significant cash position in the trust account provide some reassurance, but the looming deadline and global market uncertainties represent material risks that could impact the share price. The terms of redemption, lock-up agreements, and rights instruments are crucial for shareholders to understand, especially in light of potential liquidation scenarios.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. Readers should conduct their own due diligence and consult with financial advisors before making any investment decisions. The information herein is based on audited financial statements and management disclosures as of February 27, 2026. Future developments, business combinations, or market events may materially affect the company’s financial position and share value.

View APEX Tech Acquisition Inc. Historical chart here



Fortitude Gold Corporation 2025 Annual Report: Operational Risks, Market Analysis, and Cybersecurity Overview

Fortitude Gold Corporation 2025 Annual Report: Key Investor Insights Fortitude Gold Corporation 2025 Annual Report: Key Investor Insights Overview and Structure Fortitude Gold Corporation, organized under Colorado law on August 11, 2020, operates as...

Day One Biopharmaceuticals 2026 Outlook: OJEMDA Growth, Pipeline Updates & Financial Highlights

Day One Biopharmaceuticals Reports Strong 2025 Results, Pipeline Advancements, and 2026 Outlook Day One Biopharmaceuticals Reports Strong 2025 Results, Pipeline Advancements, and 2026 Outlook Key Highlights OJEMDA (tovorafenib) drives rapid revenue and prescription growth...

PepGen Inc. Enhanced Delivery Oligonucleotide Platform: Advancing Oligonucleotide Therapeutics for Neuromuscular and Neurologic Diseases 3940414546

PepGen Inc. 10-K Report: Key Highlights for Investors PepGen Inc. 2025 Annual Report: Investor Highlights & Price-Sensitive Details Key Points from the Report Company Overview: PepGen Inc. is a biotechnology company headquartered in Boston,...

   Ad